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Abstract
Background: Radon is an inert gas formed from the decay of naturally-occurring materials in 
the earth’s crust. It infiltrates into homes from soil, water, and construction materials. Its decay 
products are radionuclides, which attach to ambient particles. Residential radon is one of the 
leading risk factors for lung cancer. The scarce evidence for associations with other mortality 
causes originates mostly from occupational studies.
Methods: In a cohort study with 14 years of follow-up (2000-2013), we evaluated the association 
between chronic radon exposure and all-cause mortality, and explored whether there are 
subpopulations who are more vulnerable to radon effects. We included 87,296,195 person-years of 
follow-up from all Medicare beneficiaries in the Mid-Atlantic and Northeastern U.S. states. We 
examined the association between the logarithm of county-averaged radon (ln(Rn)) and mortality 
and assessed effect modification by chronic conditions.
Results: An interquartile range increase in the ln(Rn) was associated with a 2·62% increase (95% 
CI 2·52%; 2·73%) in mortality, independent of PM2.5 exposure. Larger mortality risks were 
observed among individuals with respiratory, cardiovascular and metabolic diseases, with the 
highest associations observed among those with diabetes (4·98% increase), heart failure (4·58% 
increase), and chronic obstructive pulmonary disease (4·49% increase).
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Conclusion: We found an increased risk for all-cause mortality associated with increased radon 
exposure. The risk was enhanced among susceptible individuals with chronic conditions. We 
believe this is the first cohort study to identify populations at higher risk for non-malignant health 
consequences of radon exposure. Due to the limitations in exposure assessment and availability of 
individual confounders, these findings should be interpreted with caution.
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1. Introduction
Radon is an inert gas formed from the decay of naturally-occurring materials in the earth’s 
crust. It infiltrates into homes from soil, water and construction materials, and can 
accumulate to high levels in enclosed spaces with poor ventilation1. Radon gas decays into 
radioactive progeny, which quickly react with water vapor and trace atmospheric gases to 
form fast diffusing ultrafine clusters. These clusters then attach to airborne particles and can 
be inhaled2. Radon progeny continue to decay after inhalation and deposition, which 
exposes the lung and other tissues to high energy α-particles that otherwise, could not 
penetrate the epidermis. Therefore, it is a significant source of human exposure to alpha 
radiation3. Radon through its progeny is the primary source of naturally-occurring radiation 
exposure in the U.S. population4,5
Radon decay products are known carcinogenic agents, and exposure to radon is a well-
established risk factor for lung cancer The continuing radioactive decay in the lungs is 
believed to induce the carcinogenesis process 6. A recent study found a 34% increased risk 
for lung cancer death among study participants who were exposed to radon levels above the 
U.S. Environmental Protection Agency guidelines threshold of 4 pCi/L (148 Bq/m3)7.
Radon exposure has been found to be related to outcomes other than lung cancer5,8,9, but the 
evidence is scarce and inconsistent. Turner et al found a positive association between radon 
exposure and COPD7, but found no evidence for an association between radon exposure and 
non-respiratory mortality10. Similarly, evidence from a collaborative analysis of 11 cohorts 
among miners concluded that mortality from cancers other than lung cancer is unlikely to be 
caused by radon11. Studies that have found positive associations between radon and non-
respiratory mortality are subject to significant limitations, including potential bias from the 
study design and confounding. For example, a case-cohort study among Czech uranium 
miners has found a positive association between radon exposure and leukemia. However, a 
potential exposure measurement error, especially for high exposures acquired in the early 
study period, is a major limitation of this study12. Other ecological studies have found 
associations between radon and leukemia, both among miners and in the general population. 
However, these results may be subjected to biases which are common in ecological study 
designs13. Another example is a study of French uranium miners that found a significant 
increase in cerebrovascular mortality associated with cumulative radon exposure, but could 
not fully adjust for confounding by cardiovascular risk factors 8.
Sade et al. Page 2
Environ Int. Author manuscript; available in PMC 2020 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Our study addresses this knowledge gap by investigating the association between radon 
exposure and all-cause mortality using individual mortality and hospital admissions data of 
all Medicare beneficiaries in the Mid-Atlantic and Northeastern U.S. states for the period 
2000 to 2013. In addition, we explore whether certain subpopulations are more susceptible 
to radon exposures.
2. Methods
2.1. Study population
We included all Medicare beneficiaries 65 years and older who were included in the Fee-
For-Service program and who resided in the following Mid-Atlantic and Northeastern states 
including: Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, 
New York, New Jersey, Delaware, Pennsylvania, Maryland, Washington, D.C., Virginia, and 
West Virginia, for the years 2000 to 2013. Medicare is an open cohort; each enrollee either 
entered the cohort in 2000 or after 2000 when they turned 65. Subjects who were alive on 
January 1 of the year following their enrollment in Medicare entered the open cohort. For 
each enrollee, a record was created for each year of follow-up, and each subject was 
followed annually until the year of their death or the end of our study period (December 31, 
2013). The outcome of this analysis was all-cause mortality. This study was approved by the 
Harvard T.H. Chan School of Public Health Human Subjects Committee.
2.2. Exposure data
We obtained county mean radon levels, modeled by the Lawrence Berkeley National 
Laboratory (LBL). The data was available for 309 of the 411 counties in the study area. In 
brief, long-term average indoor living area radon concentrations were estimated using the 
EPA/State Residential Radon Surveys SRRS short-term measurements14, long-term indoor 
radon measurements, and additional regional characteristics including geologic and housing 
characteristics15,16. Long-term indoor radon concentrations have been demonstrated to 
depend largely on geologic and soil information as well as house construction16. As these 
factors do not change rapidly with time, therefore, we expect long-term radon to remain 
relatively consistent. As a result, we treated these historic residential radon levels as 
indicators of chronic exposure7,17, and we assigned to each study participant the mean radon 
value from the county containing that participant’s ZIP code.
As a sensitivity analysis, we used a second measure of radon concentrations obtained from 
the SRRS, in which approximately 60,000 measurements were collected during 1987-1992 
to estimate county-level mean indoor radon levels14. The majority of state-level surveys 
were conducted by the U.S. EPA using short-term charcoal canister samplers in the winter, 
which were exposed for approximately seven days in the lowest livable level of each 
residence18. These measures were available for 399 counties (97%).
2.3. Other covariates
2.3.1. Individual data: Medicare data on the participant’s age at entry, sex, race, date of 
death, ZIP code of residence, dual eligibility for the Medicare and Medicaid service, and 
primary and secondary admission causes. Participants were defined as having a condition if 
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they had at least one emergency admission for the following outcomes, classified by the 
International Classification of Disease ninth revision codes (ICD-9) as follows: chronic 
obstructive pulmonary disease (COPD; ICD-9 490–496, except 493), diabetes (ICD-9 250), 
congestive heart failure (CHF; ICD-9 428), ischemic stroke (ICD-9 433-435), and 
myocardial infarction (MI; ICD-9 410).
2.3.2. Neighborhood socioeconomic data: We obtained the following ZIP code 
level socioeconomic status (SES) variables from the 2000 U.S. Census and the American 
Community Survey (ACS) 5-year estimates for 2009–2013: median household income, 
population density, and percent of residents with no high school education. We also obtained 
age-adjusted yearly prevalence estimates of smoking from the Centers for Disease Control 
and Prevention (CDC) Behavioral Risk Factor Surveillance System (BRFSS)19.
2.3.3. Fine particulate matter (PM2.5) exposure: We obtained highly spatially-
resolved PM2.5 data (1×1 km resolution) from a hybrid Aerosol Optical Depth (AOD) based 
model, which incorporates daily satellite remote sensing data and classic LUR 
methodologies. For more in-depth description, please refer to Kloog et al20. The exposure 
values of all grid cells located within each ZIP code and a 500 m buffer around the ZIP code 
borders were averaged annually and assigned to participants based on the ZIP codes 
corresponding to their residential address.
2.4. Statistical analysis
We used mixed Poisson survival analysis21 using the Anderson-Gill formulation with a 
random intercept for each ZIP code, time-fixed predictors (radon exposure, sex, race), and 
time-varying predictors (age, diabetes, congestive heart failure (CHF), chronic obstructive 
pulmonary disease (COPD), myocardial infarction (MI), stroke, annual ZIP code level PM2.5 
concentration, population density, median household income, percent of residents without a 
high school diploma, and percent smokers). Because each subject has time-varying 
confounders, we fit a proportional hazard model using the equivalent Poisson regression. We 
generated an artificial Poisson observation for each subject in the risk set at each non-
censored year with an outcome of zero for all person-years except those experiencing the 
event at that time. We allowed a piecewise constant hazard for each year by adding a 
penalized spline function of year21.
As the mean Rn distribution was highly skewed, we defined the log of county-averaged 
radon, ln(Rn), as the main exposure of interest.
The model is:
Log E Yi, z = β0 + β1Xc + β2Uz, t + β3Wi, + β4Wi, t + s t
where Yi,z is the outcome of person i, in ZIP code z; Xc is the ln(Rn) associated with county 
c; Uz,t are spatial and temporal confounders that vary between ZIP codes and overtime 
(PM2.5, median household income, population density, percent population with no high 
school diploma, and percent smokers); Wi are the person’s individual confounders that do 
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not vary over time (race and sex); Wi,t are the person’s individual confounders that do vary 
over time (age, diabetes, CHF, MI, stroke, and COPD); and s(t) is a penalized spline for year 
of study.
To identify susceptible populations, we repeated our model to assess the association between 
ln(Rn) and all-cause mortality and added multiplicative interaction terms with each of the 
following morbidities separately: COPD, CHF, MI, ischemic stroke, and diabetes.
To further explore the potential non-linear effects of radon we also ran a version of the 
model using a regression spline with three degrees of freedom for the ln(Rn) term, instead of 
a linear term. In addition, to explore the potential joint synergistic effect of PM2.5 and radon, 
we also ran a version of the main analysis adding a multiplicative interaction term between 
PM2.5 and ln(Rn).
Finally, results are presented as percent change and 95% confidence interval per interquartile 
range increase (IQR) in the ln(Rn).
To make sure the associations found in our study are not driven by lung cancer mortality 
alone, we added a sensitivity analysis in which we repeated our model with the exclusion of 
persons who, at any time, had been admitted to the hospital with a primary or secondary 
diagnosis of lung cancer.
3. Theory
An association between radon exposure and non-respiratory and non-malignant mortality 
causes is biologically plausible. Non-malignant effects can result from a radiation-induced 
cell activation, which may directly damage the organ structure and impair their functionality 
22
. Although radon exposure has been found to be related to non-respiratory malignant and 
nonmalignant outcomes5,8,9, the evidence is scarce and inconsistent. While most studies 
found no clear associations with non-respiratory mortality23,24, some found increased 
risks5,8,9. Furthermore, while several recent radon studies have focused on the general 
population, most of them have investigated the effects of occupational exposures which are 
considerably higher. Therefore, little is known about non-malignant health effects of 
residential radon exposure25.
4. Results
We included 87,296,195 person-years of follow-up for 13,045,126 persons 65 years and 
older. This population is 42.8% male, majority white, and has a mean age of 79 years at 
death or the end of follow up. From the participants, 2·8% were diagnosed with COPD, 
0·3% MI, 3·5% CHF, 0·3% stroke, and 2·8% diabetes. 35 · 8% died at the end of follow-up 
(Table 1).
The county-averaged radon concentration ranged from 6·6 to 265·6 Bq/m3, with a mean 
value of 50·0 Bq/m3 (Figure 1).
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The 25th and 75th percentiles of ln(Rn) were 3·4 and 4·0, respectively, yielding an IQR of 
0·6. This IQR corresponds to 24.6 Bq/m3 and 0.7 pCi/L. The mean annual PM2.5 
concentration during the study period was 10·7 μg/m3 and ranged from 4·0 to 28·5 μg/m3 
(IQR=3·0 μg/m3). A low correlation was observed between ln(Rn) and annual PM2.5 
(r=0·03, p<0·001). Of the predictors included in the models, the highest correlation was 
observed between ln(Rn) and population density (r=−0·09, p<0·001).
An IQR increase in the ln(Rn) was associated with 2·62% increase (95% CI: (2·52%; 
2·73%)) in all-cause mortality. Without adjustment for PM2.5, the effect size for the 
association with radon remained similar (2·61% increase; 95% CI (2·51%; 2·72%)). 
Similarly, the PM2.5 effect did not change with the exclusion of ln(Rn) in the model. In a 
model with ln(Rn), an IQR increase of 3 μg/m3 in PM2.5 was associated with 5·83% increase 
in mortality (5·58%; 6·09%); in a model without the ln(Rn) term, an increase of 3·0 μg/m3 
was associated with 5·80% increase in mortality (5·54%; 6·05%).
Larger mortality risks were observed among persons with COPD (4·49% increase in 
mortality, interaction p value<0·001), CHF (4·58% increase in mortality, interaction p 
value<0·001), and diabetes (4·98% increase in mortality, interaction p-value <0·001). MI and 
stroke did not modify the association with radon (Table 2).
When allowing for a nonlinear association between mortality and ln(Rn) within the Poisson 
log-linear model, we observed a weak protective effect at lower radon levels followed by an 
increased mortality risk with increasing ln(Rn) for exposure values between 3 and 4·5 Bq/m3 
(Figure 2).
When assessing the interaction between ln(Rn) and PM2.5 we found a significant negative 
interaction which indicates larger ln(Rn) effects in lower exposure to PM2.5.
We conducted sensitivity analyses to make sure our findings are consistent. First, when we 
repeated our model with the exclusion of persons who were diagnosed with lung cancer, the 
association remained similar (2.87% increase, 95% CI 2.76%; 2.97%). Second, in a 
sensitivity analysis among the 309 counties for which we had available SRSS radon 
measurements, we still observed a positive and statistically significant association between 
radon exposure and mortality (1·44% increase; 95% CI (1·36%; 1·52%)). Like the main 
analysis, we observed a statistically significant interaction with stroke. However, we found 
no interaction with the other morbidities tested.
5. Discussion
We found an increased risk for all-cause mortality associated with residential radon 
exposure. The association was robust to the exclusion of persons who were diagnosed with 
lung cancer. People with respiratory, circulatory or metabolic diseases appeared to be more 
susceptible to radon exposure. The dose-response curve for all-cause mortality was 
nonlinear, and higher mortality risks with increasing radon levels were found only for 
exposures around the median of the ln(Rn) distribution.
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We studied both the effect of ln(Rn) and PM2.5 on mortality and found that the correlation 
between the exposures was low and that the association with each exposure was not 
confounded by the other. The primary factor in determining radon-related radiation dose is 
the activity size distribution of decay products, which determines the amount of inhaled 
activity deposited in the lungs and the final deposition location. The activity size 
distribution, in turn, is governed by the size and concentration of atmospheric aerosols, 
including PM2.526.
Unlike our initial hypothesis, we found a negative interaction between PM2.5 and radon. In a 
previous analysis done by our group found a synergistic effect of radon and PM2.5. In this 
analysis, city-specific estimates of average indoor radon (both SRRS and LBL 
measurements) were associated with increased PM2.5-related total, cardiovascular and 
respiratory mortality risk, with stronger mortality effects of PM2.5 in cities with high average 
indoor radon concentrations 27. Although both of these studies assessed the interaction 
between PM2.5 and radon, they are very different in their design. First, this previous study 
focused on effect modification of radon on PM2.5-associated daily mortality in 108 U.S. 
cities, and our study looks at chronic effects of radon on all-cause mortality. Second, the 
previous study analyzed city level counts of mortality cases, while our study population 
comprises individuals with annual follow up data. The negative interaction observed in our 
study may be related to residual confounding due to the nonlinear effect of radon. It is also 
possible that part of the radon effect is captured by the PM2.5 effect which resulted in a 
negative interaction between the two exposures.
The association between radon and lung cancer mortality, both in occupational and 
environmental settings, is well established28,29. Associations between radon and other 
mortality causes are inconsistent across existing studies. Increased levels of indoor radon 
exposure were associated with higher risk for non-Hodgkin’s lymphoma (NHL) among 
female children and adolescents in Korea31. In Colorado, however, mortality from NHL was 
not associated with cumulative radon exposure32. Contradicting results were also found 
when studying the association with leukemia33,34, stomach cancer23 urinary cancer35, and 
cardiovascular mortality8,10. We found a significantly higher risk for all-cause mortality to 
be associated with increasing residential radon exposure, supporting the growing evidence of 
links between radon and non-malignant mortality.
Moreover, we identified patients with diabetes, COPD, and CHF as more susceptible to the 
radon effect. The effect of radon on human tissue involves the formation of DNA mutations, 
DNA lesions and may damage neighboring tissue by inducing oxidative stress in adjacent 
non-irradiated cells. These processes, which were found to increase genetic susceptibility 
among lung cancer patients who were lacking specific genes36, may also play a role in 
patients with non-malignant respiratory, circulatory, and metabolic disorders.
To our knowledge, this is the first large-scale study to identify these patients as more 
susceptible to the radon effect on mortality risk. There are studies, however, that found 
associations between radon exposure and morbidity or cause-specific mortality from these 
diseases, mostly from COPD. The Cancer Prevention Study-II, a longitudinal analysis of 
nearly 1.2 million Americans, found a significant increase in the risk of COPD mortality, 
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associated with residential radon exposure17. Similarly, a study in Spain found higher radon 
exposure to be associated with an increased risk for COPD hospital admissions37. When 
testing the nonlinear effect of radon, we found it increased total mortality risks only for 
levels around the median value of exposure. In lower levels, ln(Rn) had a protective effect. 
The same pattern was observed by Duan et al6 who assessed the association between radon 
exposure and lung cancer. The authors attributed the protective effect to an adaptive 
response, which enhanced the DNA repair capacity among exposed individuals. They 
hypothesized that low radon exposure might stimulate apoptosis and immunity and, 
therefore, provide protection against an oxidative tissue damage.
One major strength of this study is its inclusion of a large cohort followed over 14 years. In 
addition, we assessed the relationship between radon and PM2.5 exposure in a non-
occupational setting, providing more evidence on the health risks associated with these 
environmental exposures in the general population.
A major limitation of this study is the radon exposure assessment, which was estimated at a 
county level and was assumed fixed over time. This leaves a potential for spatial 
confounding, although we did adjust for some spatial characteristics including income, 
education, and population density. It also adds additional Berkson error as we assume the 
same exposure for all individuals living in the same county. We added a sensitivity analysis 
using a different source for exposure data, which supported our main findings. In addition, 
we were not able to explore the role of season in the radon-mortality relationship because 
the study utilizes annual follow-up of health.
Finally, we did not have information on important individual confounders (such as smoking, 
income and BMI). Although we could not adjust for individual smoking or income, we did 
adjust for the smoking rate and SES at the neighborhood level. A previous study, performed 
among this study population, investigated how the lack of adjustment for smoking, BMI and 
income could have resulted in residual confounding. They obtained individual data from a 
representative subsample of Medicare enrollees and found that smoking and income were 
not associated with PM2.5 or ozone and therefore were not likely to confound the association 
with mortality 38. This supports the use of neighborhood smoking rate to remove 
confounding by smoking status. Regarding SES, we did control for individual race and 
eligibility to Medicaid – which can serve as a proxy for socioeconomic status. Additionally, 
we observed a very low correlation between the mean county level and the neighborhood 
SES characteristics, which supports the assumption that there is no residual confounding by 
SES.
6. Conclusion
In conclusion, we found an increased risk for all-cause mortality, associated with increased 
radon exposure, independent of exposure to PM2.5. The risk was enhanced among 
susceptible individuals with respiratory, cardiovascular, and metabolic conditions. Due to the 
limitations in exposure assessment and availability of individual confounders, these findings 
should be interpreted with caution.
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Highlights
• County-level radon was associated with an increased risk for all-cause 
mortality
• The risk remained after the exclusion of lung cancer morbidity cases
• Respiratory, cardiovascular and metabolic diseases increased susceptibility to 
radon
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Figure 1. 
County mean radon level by quartiles
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Figure 2. The non-linear association between radon and mortality
Figure 2 shows the dose response curves for the association between penalized spline of 
ln(Rn) and all-cause mortality. The dashed lines represent the quartiles of the log of radon.
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Table 1.
Population characteristics during 2000-2013
COPD=Chronic Obstructive Pulmonary Disease; MI=Myocardial Infarction; CHF=Congestive Heart Failure
Population characteristics N=13,045,126
Male gender, No. (%) 5,588,039 (42·8)
Race, No. (%)
White 11,412,678 (87·5)
Black 1,223,583 (9·4)
Other 408,865 (3·1)
Age, Mean (SD), years 77.93 (8·6)
Comorbidities, No. (%)
COPD 371,553 (2·8)
MI 33,165 (0·3)
CHF 456,500 (3·5)
Ischemic stroke 38,046 (0·3)
Diabetes mellitus 366,756 (2·8)
Death, No. (%) 4,674,731 (35·8)
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Table 2.
The association between radon and mortality among all study participants and 
individuals with respiratory, cardiovascular and metabolic diseases
Table 2 shows the % change in all-cause mortality associated with IQR increase in ln(Rn) (0·6 units) among 
all study participants and individuals with chronic obstructive pulmonary disease (COPD), congestive heart 
failure (CHF), myocardial infarction (MI), ischemic stroke or diabetes mellitus (DM). The effects reported 
among individuals with the comorbidities above were obtained by adding multiplicative interaction terms with 
each morbidity separately.
Percent change (95% CI) Interaction p value
All available data 2·62% (2·52%; 2·73%)
COPD
No 2·59% (1·80%; 3·39%)
Yes 4·49% (3·69%; 5·30%) <0·001
CHF
No 2·58% (1·88%; 3·28%)
Yes 4·58% (3·88%; 5·29%) <0·001
MI
No 2·63% (0·28% 53·03%)
Yes 0·65% (−1·64%; 3·00%) 0·099
Stroke
No 2·62% (0·42%; 4·84%)
Yes 4·19% (1·96%; 6·47%) 0·168
DM
No 2·59% (1·73%; 3·46%)
Yes 4·98% (4· 10%; 5·86%) <0·001
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